Marrow has raised $2m in pre-seed funding, led by Insurtech Gateway. The London-based company, formerly called Malcolm, connects insurers to AI agents and assistants.
Evertrace spotted Tim Graham, co-founder of Marrow, 208 days before the funding announcement.
Before the round
| Evertrace detected the signal | 28 March 2026 |
|---|---|
| Funding announced | 22 October 2026 |
| Time before the announcement | 208 days |
On 28 March 2026, Evertrace detected the first signal of company formation for Tim Graham. That was 208 days before Marrow's funding announcement.
Tim Graham previously led product at the insurer Ki. Marrow's co-founders include Adam Mesout.
What they’re building
More people now ask AI assistants for help with buying insurance. Marrow provides a standard infrastructure layer that connects insurers' pricing, underwriting and policy systems to AI agents and assistants.
Its protocol lets insurers sell through AI-driven channels while they keep regulatory control, disclosures and record-keeping. Marrow has published the AMI Standards for AI-led insurance transactions.
The round
Insurtech Gateway led the $2m pre-seed round, with Seed X, Leo Capital, Portfolio Ventures and angel investors. Marrow will use the funding to grow its team in London, bring on more insurers across retail and commercial lines and continue to develop the AMI Standards.
Find your next investment before the round. Explore Evertrace →
The founder detection engine for VCs
AI-powered founder detection with unmatched coverage.
Book a demo